“With CalRx, we are getting at the underlying cost, which is the true sustainable solution to high-cost pharmaceuticals,” Newsom wrote in a message explaining why he vetoed the bill on Saturday. “With co-pay caps however, the long-term costs are still passed down to consumers through higher premiums from health plans.”
Makes sense, when you block a corporation by increasing taxes, they will always pass the “new” cost to the consumers, in this case the “competition” will provide true lower costs…
“With CalRx, we are getting at the underlying cost, which is the true sustainable solution to high-cost pharmaceuticals,” Newsom wrote in a message explaining why he vetoed the bill on Saturday. “With co-pay caps however, the long-term costs are still passed down to consumers through higher premiums from health plans.”
Makes sense, when you block a corporation by increasing taxes, they will always pass the “new” cost to the consumers, in this case the “competition” will provide true lower costs…